Diagnosing antisocial personality disorder among substance abusers: The SCID versus the MCMI-II

American Journal of Drug and Alcohol Abuse

Volumn 27, Issue 4, 2001, Pages 699-717

  Messina, N ^a   Wish, E ^a   Hoffman, J ^a   Nemes, S ^a  

^a Center for Substance Abuse Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANTISOCIAL BEHAVIOR; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MILLON CLINICAL MULTIAXIAL INVENTORY; PERSONALITY TEST; PSYCHIATRIC DIAGNOSIS; RATING SCALE; SELF REPORT; SUBSTANCE ABUSE;

ADULT; ANTISOCIAL PERSONALITY DISORDER; COMORBIDITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED; PERSONALITY INVENTORY; PREVALENCE; REPRODUCIBILITY OF RESULTS; SUBSTANCE-RELATED DISORDERS;

EID: 0035174696     PISSN: 00952990     EISSN: None     Source Type: Journal    
DOI: 10.1081/ADA-100107663     Document Type: Article

References (51)

1. The effect of co-occurring disorders on criminal career: Interaction of antisocial personality alcoholism and drug disorders
2. Arrest rates of patients treated at a Community Health Center
3. The criminality of mentally disordered offenders
4. Psychiatric and substance abuse disorders among male urban jail detainees
5. Therapeutic community: Advances in research and application
6. Antisocial personality disorder in patients with substance abuse disorders: A problematic diagnosis?
7. Treatment in residential therapeutic communities
8. Genetics of personality disorders: Perspectives from personality and psychopathology research
9. Antisocial personality
10. Preliminary results from a controlled clinical trial of behavior therapy for antisocial opioid abusers
11. Psychopathy and violence
12. Validity of the SCID in substance abuse patients
13. Cultural considerations using the structured clinical interview for DSM-III for mood and anxiety disorders assessment
14. A comparison of the differential diagnostic efficiency of three personality disorder inventories
15. Comparison of measures used to determine substance abuse in a inpatient psychiatric population
16. Validity of the personality diagnostic questionnaire - Revised: Comparison with two structured interviews
17. Personality disorders classification and symptoms in cocaine and opioid addicts
18. Diagnosing comorbidity in substance abusers computer assessment and clinical validation
19. A coefficient of agreement for nominal scales
20. Developing criteria for establishing interrater reliability of specific items: Applications to the assessment of adaptive behavior
21. Problems and considerations in the valid assessment of personality disorders
22. Diagnosing comorbidity in substance abusers: A comparison of the test-retest reliability of two interviews
23. Validity of the SCID in substance abuse patients
24. Validity of the longitudinal expert, all data procedure for psychiatric diagnosis in patients with psychoactive substance use disorders
25. Validating structured DSM-III-R personality disorder assessments with longitudinal data
26. Validity of the MCMI drug abuse scale with drug abusing and psychiatric samples
27. MCMI comparisons of cocaine abusers and heroin addicts
28. Assessing drug abusers with the millon clinical multiaxial inventory: A review
29. A selected review of the MCMI empirical literature
30. Sensitivity of MCMI-III scales T (drugs) and B (alcohol) in detecting substance abuse
31. Psychopathology in alcohol-dependent and cocaine-dependent patients: A comparison of findings from psychological testing
32. A comparison of continuous and episodic drinkers using the MCMI MMPI and A1CEVAL-R
33. The reliability of axis II of DSM-III-R
34. The MCMI provides a good assessment of DSM-III disorders: The MCMI-II will prove even better
35. Putting humpty dumpty together again: Using the MCMI in psychological assessment
36. The centralized intake model for drug abuse treatment: The role of computerized data management
37. Comparing the impact of standard and abbreviated treatment in a therapeutic community: Findings from the District of Columbia treatment initiative experiment
38. The individual assessment profile (IAP): Standardizing the assessment of substance abusers
39. Program description and outcome of a enhanced six months residential therapeutic community
40. Personality disorders
41. The structured clinical interview for DSM-III-R axis II and the millon clinical multiaxial inventory: A concurrent validity study of personality disorders among anxious outpatients
42. Legal pressure in therapeutic communities